Interested in investing in EIS and VCT?
Looking for strategic support and financial backing?
The Calculus Capital EIS Fund benefits from the generous tax incentives currently offered by the Government for investment into smaller UK companies as part of the Enterprise Investment Scheme (EIS).
The Calculus VCT has a strong track record of delivering regular dividends to investors. Investors also enjoy tax reliefs including income tax relief of up to 30% and tax free dividends.
Calculus Capital has over 20 years’ experience investing in small and medium sized companies. We pride ourselves on working in partnership with our investee companies, taking a seat on the board and providing advice on a strategic level when required – with the ultimate aim of realising the full potential of the business and its management.
Meet the company: Synpromics, gene therapy to develop cures for genetic diseases
RT: Arecor drug entering clinical trials, Scancell drug entering clinical trial with prospect of two more clinical trials in 2020, Blu Wireless working with govt & train companies on ultra-fast connectivity in auto & transport sectors - interesting developments in Calculus' portfolio
The Calculus EIS Fund is now open for subscription